Trial Profile
Formoterol-beclomethasone in patients with bronchiectasis: a randomized, double-blind, placebo-controlled trial (Forza study)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2023
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- Acronyms FORZA
- 13 Sep 2023 Results presented at the 33rd Annual Congress of the European Respiratory Society
- 28 Feb 2023 Status changed from recruiting to discontinued.
- 24 Mar 2022 Planned End Date changed from 1 Dec 2019 to 1 Jun 2023.